Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HIMS
HIMS & HERS HEALTH, INC.
NYSE
$28.84
▼ DOWN 8.91% (-2.82)

KEY STATISTICS

Market Cap$6.43 B
52w High$65.30
52w Low$13.74
Dividend Yield—
Frequency—
P/E-45.06
Volume14.66M
Shares Out.223.08M

COMPANY

LEADERSHIP

Andrew Dudum
CHIEF EXECUTIVE
Andrew Dudum

COMPENSATION 2026

Salary$494,792
Stock Awards$10,635,352
Incentive Plan Pay$585,763
All Other Comp.$243,000
Total$22,958,907

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 13, 2019
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
2,442

PRICE TARGET

Target High$42.00
Target Low$12.50
Target Median$30.00
Target Consensus$30.20

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$890.88M
NOV
9
MON

PRICE

$28.84 ▼ DOWN 8.91% (−$2.82)
$29.00$30.00$31.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM28.84

About Hims & Hers Health, Inc.

https://www.hims.com ↗

Hims & Hers Health is a San Francisco-based telehealth platform offering healthcare services, prescription medications, and wellness, skincare, sexual health, and hair care products directly to consumers.

INDUSTRY

Medical - Care Facilities

A PRODUCT HIMS & HERS HEALTH, INC. IS KNOWN FOR

Compounded GLP-1 Injections
Compounded GLP-1 Injections

Hims & Hers offers a prescription injectable weight loss medication through a telehealth program, marking their entry into the weight management market with accessible and affordable treatment options.

COMPETITORS

COMPETITOR
GDRX COMPARE
HQY COMPARE
LFMD COMPARE
TDOC COMPARE
WW COMPARE

Revenue by Geography

MapREGIONQ1-2026Q2-2026
UNITED STATES$529.91M $621.83M ▲
NonUS$78.19M $131.38M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
194
LISTED HERE
26
RANKED BY POSITION SIZE
XAW.TO
0.01% · 7.4M
VTS.AX
0.01% · 6.7M
MDY
0.18% · 1.6M
SCHA
0.14% · 1.0M
NUSC
0.42% · 209.3K
XRSU.L
0.21% · 195.0K
FESM
0.07% · 146.8K
PTH
1.64% · 145.7K
IBUY
2.38% · 106.2K
FNY
0.56% · 105.9K
RSSL
0.21% · 103.2K
JMEE
0.11% · 100.2K
GSSC
0.15% · 52.0K
BUZZ
1.57% · 49.1K
ULTI
4.82% · 33.2K
BKMC
0.14% · 31.6K
AVUS
0.01% · 28.0K
VETS
0.16% · 23.9K
JHSC
0.09% · 22.3K
EZM
0.06% · 19.2K
ZMID.TO
0.19% · 15.1K
URTY
0.08% · 8.8K
RTWO.L
0.11% · 8.0K
STXK
0.27% · 7.9K
TILT
0.01% · 6.0K
ACSG
0.34% · 5.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
75.52%
HOLDERS
742
TOP 12 OF 742 · RANKED BY POSITION SIZE
Blackrock, Inc.
28.7M sh · $995.15M
Vanguard Group Inc
20.9M sh · $679.46M
Jpmorgan Chase & Co
18.8M sh · $611.68M
Capital World Investors
18.8M sh · $1.07B
Blackrock Inc.
14.6M sh · $294.25M
Farallon Capital Management LLC
10.7M sh · $609.56M
Goldman Sachs Group Inc
10.3M sh · $335.98M
Forerunner Ventures Management, LLC
9.8M sh · $86.84M
Newview Hms Spv Partners, LLC
9.7M sh · $53.92M
Renaissance Technologies LLC
9.1M sh · $515.97M
Morgan Stanley
8.9M sh · $184.54M
State Street Corp
8.1M sh · $282.41M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Dudum Andrew
Sale · 977.6K shares
2026-08-27
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Dudum Andrew
Sale · 463.3K shares
2026-08-25
★
OFFICER: CHIEF LEGAL OFFICER
Boughton Soleil
Sale · 25.1K shares
2026-08-19
★
DIRECTOR, OFFICER: CHIEF POLICY OFFICER
Autor Deborah M.
Sale · 16.8K shares
2026-08-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 3
NEUTRAL 3
OVERWEIGHT 2
BUY 2
EQUAL WEIGHT 1
MARKET PERFORM 1
IN LINE 1
13 GRADES IN THE LAST 12 MONTHS
Truist Securities HOLD Barclays OVERWEIGHT Deutsche Bank HOLD Needham BUY Citigroup NEUTRAL Morgan Stanley EQUAL WEIGHT B of A Securities NEUTRAL TD Cowen HOLD

SECTORS PEERS

PEERPRICE
MRNA$137.99COMPARE
RVTY$128.80COMPARE
BAX$26.13COMPARE
PEN$321.68COMPARE
BMRN$64.67COMPARE
TECH$72.35COMPARE
ALGN$157.58COMPARE
ENSG$172.98COMPARE